about
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesHuman fetal tau protein isoform: possibilities for Alzheimer's disease treatmentEarly failure of the default-mode network and the pathogenesis of Alzheimer's diseaseCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationEndosomal location of dopamine receptors in neuronal cell cytoplasmUpdate on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Extraordinary neoteny of synaptic spines in the human prefrontal cortex.Pathological tau proteins in argyrophilic grain disease.Does Alzheimer's disease begin in the brainstem?Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.Monoaminergic neuropathology in Alzheimer's disease.Atomic force microscopy as an advanced tool in neuroscience.Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.Neuroplastin deletion in glutamatergic neurons impairs selective brain functions and calcium regulation: implication for cognitive deterioration.Comparison of two commercial enzyme-linked immunosorbent assays for cerebrospinal fluid measurement of amyloid β1-42 and total tau.Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia.Comparative analysis of the nucleus basalis of Meynert among primates.Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.In search of the definitive Brodmann's map of cortical areas in human.Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease.Hemispheric asymmetry, modular variability and age-related changes in the human entorhinal cortex.Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia.The reliability and validity of the mini-mental state examination in the elderly Croatian population.Coevolution in the timing of GABAergic and pyramidal neuron maturation in primates.Stathmin is enriched in the developing corticospinal tract.nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease.The interactions of p53 with tau and Aß represent potential therapeutic targets for Alzheimer's disease.Treatment strategies for spinal muscular atrophyHuman neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein speciesAssociation of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohortHyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and sphingolipid mediators as a therapeutic targetMolecular Mechanisms of Neurodegeneration Related to Hexanucleotide Repeat ExpansionAbnormal motoneuron migration, differentiation, and axon outgrowth in spinal muscular atrophyEvent-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer's DiseaseRelationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide PolymorphismsA non-invasive hidden-goal test for spatial orientation deficit detection in subjects with suspected mild cognitive impairmentRare diseases and omics-driven personalized medicine
P50
Q26769957-9EC1A31D-111C-49E8-B102-D3254D26D92BQ26829893-18EBE911-BEC2-4AC3-9E8E-2D5E3D2096FAQ26862463-8F0A41B9-182C-426A-8DC3-27EA1934D60EQ28087030-A005B106-9B4B-488C-B48F-A627B8D7FC5EQ28581879-F25BCDE3-21E5-431B-BEDE-4C61A158FFA7Q30845482-622C34F4-B52A-425E-B67B-C8F88281C76EQ34203392-DF17DF55-6183-4B6B-8167-3BDE8BA9E911Q35172422-B8A028DE-C4C5-4197-8A5E-9E22A0C35D16Q37456054-9B1B2DED-4AB1-4A56-8F61-6ED111305053Q37634353-5FFBE90B-F689-4BB4-AB62-BA806C209416Q38809649-55E92C77-A965-442B-85E7-E28EA2490DE5Q38998492-A1C6E3EE-BBC6-43CE-BE2A-02FB1AE9B92DQ40032161-EDB68836-4FA0-44A6-A986-75B8828DC5FEQ41160304-158C545C-D0CD-47E2-A5F6-E835C8AA8D86Q41260786-04827D0D-570C-4CB2-ADE4-D23104486605Q41788413-72583A6D-CEBF-4462-99E7-1338E264CCF2Q41874352-753F6628-543F-4E06-B0A1-FC4180D87D8FQ42486984-674C4799-B6D6-4261-BD12-739A2593833EQ45754969-3AD4CD20-1DEE-4C3B-9F9F-DA6FFA4ED298Q48741053-E54DA1B6-6F66-49A8-9B3A-594866260335Q48761548-5D35AE3C-4AA0-4434-8350-E9FC0DF0E1B7Q49144335-ABBDD27B-1D3A-4713-8F45-13D125ECB5B2Q49905766-54543BCA-3398-46B5-9123-E3AC4C68DD87Q50748802-726077F4-A208-4266-9F35-4370FC3F0937Q51798572-95B34A76-30AC-44E5-AE18-875BD05F7AA7Q52149281-4ECE3931-69FF-4F09-8233-7D7D46EDA665Q53342697-7CD9E001-47D5-4F55-9B95-FDF119388C6EQ53397905-AB5A794E-7799-4E2D-9A8E-1B76FF998669Q54306336-4B8D873E-3AAD-4677-A035-C804B340E970Q57065270-F571C23A-6DEC-4DF6-AC7E-BDE1C9819DC0Q57452847-8001E3EC-F4B0-4EB2-BDEB-D02234495C6EQ60620017-5658E2E2-AB77-4E23-9CB8-2A497425C892Q61816243-7F60D813-0EE7-43BB-A67D-943688D86BF5Q80187331-5FAA8F41-9179-46C7-9ABF-723750F125BDQ91399065-BAD7961E-9678-46BB-B99B-7B28DA28289FQ91467896-27027CA1-FFAD-4D5F-9D92-F89FCEAAFF89Q91921643-5B311E63-4ADA-4EC8-A212-99A99BDC6FF2Q92370661-70F91F6C-53DB-4EBA-8D72-FDADD3E6078E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Goran Šimić
@ast
Goran Šimić
@en
Goran Šimić
@es
Goran Šimić
@nl
Goran Šimić
@sl
type
label
Goran Šimić
@ast
Goran Šimić
@en
Goran Šimić
@es
Goran Šimić
@nl
Goran Šimić
@sl
prefLabel
Goran Šimić
@ast
Goran Šimić
@en
Goran Šimić
@es
Goran Šimić
@nl
Goran Šimić
@sl
P214
P106
P1153
6603352596
P214
P31
P496
0000-0002-6339-9261